Viewing Study NCT01741805


Ignite Creation Date: 2025-12-25 @ 3:30 AM
Ignite Modification Date: 2026-01-11 @ 4:54 PM
Study NCT ID: NCT01741805
Status: WITHDRAWN
Last Update Posted: 2016-07-29
First Post: 2012-12-02
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: The Clinical and Laboratory Phenotypes of Severe Asthma Patients in Clalit Health Services Haifa
Sponsor: Carmel Medical Center
Organization:

Study Overview

Official Title: The Clinical and Laboratory Phenotypes of Severe Asthma Patients in Clalit Health Services Haifa.
Status: WITHDRAWN
Status Verified Date: 2016-07
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Slow recruitment of patients
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Asthma is a chronic illness characterized by inflammation of the airways. Severe asthma is defined in the literature as asthma not controlled by medication. In recent years it has become known that severe asthma is a variable disease and has subtypes relating to the age of onset, type of inflammation and allergy, obesity, etc.

Our aim is to characterize the phenotypes of severe asthma population in our clinic and compare the prevalent phenotypes to the phenotypes described before.
Detailed Description: Study measures will include the following:

* asthma demographic and symptoms questionnaire
* Validation of proper inhaler technique
* Height, weight measurements
* Forced spirometry and reversibility testing
* DLCO
* Fractional excretion of NO in exhaled breath
* Chest and sinus CT
* Induced sputum analysis
* Complete blood count, electrolytes, immunoglobulin E, Aspergillus Specific IgE
* Skin allergy testing

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: